233 related articles for article (PubMed ID: 15642162)
1. Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells.
Zivadinovic D; Watson CS
Breast Cancer Res; 2005; 7(1):R130-44. PubMed ID: 15642162
[TBL] [Abstract][Full Text] [Related]
2. Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses.
Zivadinovic D; Gametchu B; Watson CS
Breast Cancer Res; 2005; 7(1):R101-12. PubMed ID: 15642158
[TBL] [Abstract][Full Text] [Related]
3. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways.
Bulayeva NN; Gametchu B; Watson CS
Steroids; 2004 Mar; 69(3):181-92. PubMed ID: 15072920
[TBL] [Abstract][Full Text] [Related]
5. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.
Zheng A; Kallio A; Härkönen P
Endocrinology; 2007 Jun; 148(6):2764-77. PubMed ID: 17363451
[TBL] [Abstract][Full Text] [Related]
7. Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium.
Liu Z; Yu X; Shaikh ZA
Toxicol Appl Pharmacol; 2008 May; 228(3):286-94. PubMed ID: 18275979
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
9. Non-genomic effects of 17beta-estradiol in activation of the ERK1/ERK2 pathway induces cell proliferation through upregulation of cyclin D1 expression in bovine artery endothelial cells.
Fu XD; Cui YH; Lin GP; Wang TH
Gynecol Endocrinol; 2007 Mar; 23(3):131-7. PubMed ID: 17454165
[TBL] [Abstract][Full Text] [Related]
10. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
[TBL] [Abstract][Full Text] [Related]
11. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells.
Chen DB; Bird IM; Zheng J; Magness RR
Endocrinology; 2004 Jan; 145(1):113-25. PubMed ID: 14512434
[TBL] [Abstract][Full Text] [Related]
12. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells.
Márquez DC; Pietras RJ
Oncogene; 2001 Sep; 20(39):5420-30. PubMed ID: 11571639
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
14. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
15. Region- or state-related differences in expression and activation of extracellular signal-regulated kinases (ERKs) in naïve and pain-experiencing rats.
Guo SW; Liu MG; Long YL; Ren LY; Lu ZM; Yu HY; Hou JF; Li H; Gao CY; Cui XY; An YY; Li J; Zhao LF; Chen J
BMC Neurosci; 2007 Jul; 8():53. PubMed ID: 17650295
[TBL] [Abstract][Full Text] [Related]
16. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.
Kang L; Zhang X; Xie Y; Tu Y; Wang D; Liu Z; Wang ZY
Mol Endocrinol; 2010 Apr; 24(4):709-21. PubMed ID: 20197310
[TBL] [Abstract][Full Text] [Related]
17. Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation.
Sirianni R; Chimento A; De Luca A; Casaburi I; Rizza P; Onofrio A; Iacopetta D; Puoci F; Andò S; Maggiolini M; Pezzi V
Mol Nutr Food Res; 2010 Jun; 54(6):833-40. PubMed ID: 20013881
[TBL] [Abstract][Full Text] [Related]
18. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury.
Toran-Allerand CD; Guan X; MacLusky NJ; Horvath TL; Diano S; Singh M; Connolly ES; Nethrapalli IS; Tinnikov AA
J Neurosci; 2002 Oct; 22(19):8391-401. PubMed ID: 12351713
[TBL] [Abstract][Full Text] [Related]
19. Difficulty demonstrating estradiol-mediated Erk1/2 phosphorylation in MCF-7 cells.
Brower SL; Roberts JR; Antonini JM; Miller MR
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):375-85. PubMed ID: 16019207
[TBL] [Abstract][Full Text] [Related]
20. GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals.
Gao F; Ma X; Ostmann AB; Das SK
Endocrinology; 2011 Apr; 152(4):1434-47. PubMed ID: 21303939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
